These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2663140)
61. Imaging biochemistry: applications to breast cancer. Ronen SM; Leach MO Breast Cancer Res; 2001; 3(1):36-40. PubMed ID: 11250743 [TBL] [Abstract][Full Text] [Related]
62. Evaluation of the effects of photodynamic therapy with phosphorus 31 magnetic resonance spectroscopy. Nishiwaki M; Fujise Y; Yoshida TO; Matsuzawa E; Nishiwaki Y Br J Cancer; 1999 Apr; 80(1-2):133-41. PubMed ID: 10389989 [TBL] [Abstract][Full Text] [Related]
63. Choline metabolism in breast cancer; 2H-, 13C- and 31P-NMR studies of cells and tumors. Katz-Brull R; Margalit R; Bendel P; Degani H MAGMA; 1998 Aug; 6(1):44-52. PubMed ID: 9794289 [TBL] [Abstract][Full Text] [Related]
64. Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status. Beauregard DA; Thelwall PE; Chaplin DJ; Hill SA; Adams GE; Brindle KM Br J Cancer; 1998 Jun; 77(11):1761-7. PubMed ID: 9667644 [TBL] [Abstract][Full Text] [Related]
65. Nitrogen mustard up-regulates Bcl-2 and GSH and increases NTP and PCr in HT-29 colon cancer cells. Boddie AW; Constantinou A; Williams C; Reed A Br J Cancer; 1998 May; 77(9):1395-404. PubMed ID: 9652754 [TBL] [Abstract][Full Text] [Related]
66. Growth rate, labeling index, and radiation survival of cells grown in the Matrigel thread in vitro tumor model. Casciari JJ; Chin LK; Livesey JC; Boyles D; Steen RG; Rasey JS In Vitro Cell Dev Biol Anim; 1995 Sep; 31(8):582-9. PubMed ID: 8528512 [TBL] [Abstract][Full Text] [Related]
67. Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme. Rozental JM; Cohen JD; Mehta MP; Levine RL; Hanson JM; Nickles RJ J Neurooncol; 1993 Jan; 15(1):57-66. PubMed ID: 8384254 [TBL] [Abstract][Full Text] [Related]
68. Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment. Karuri AR; Dobrowsky E; Tannock IF Br J Cancer; 1993 Dec; 68(6):1080-7. PubMed ID: 8260358 [TBL] [Abstract][Full Text] [Related]
69. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply. Lyng H; Olsen DR; Southon TE; Rofstad EK Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356 [TBL] [Abstract][Full Text] [Related]
70. Meningioma phospholipid profiles measured by 31P nuclear magnetic resonance spectroscopy. Seijo L; Merchant TE; van der Ven LT; Minsky BD; Glonek T Lipids; 1994 May; 29(5):359-64. PubMed ID: 8015367 [TBL] [Abstract][Full Text] [Related]
71. Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging. Mueller-Klieser W; Walenta S Histochem J; 1993 Jun; 25(6):407-20. PubMed ID: 7689547 [TBL] [Abstract][Full Text] [Related]
72. The assessment of treatment response in non-Hodgkin's lymphoma by image guided 31P magnetic resonance spectroscopy. Smith SR; Martin PA; Davies JM; Edwards RH; Stevens AN Br J Cancer; 1990 Mar; 61(3):485-90. PubMed ID: 2328218 [TBL] [Abstract][Full Text] [Related]
73. Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS. Baluch S; Midwood CJ; Griffiths JR; Stubbs M; Coombes RC Br J Cancer; 1991 Jun; 63(6):901-4. PubMed ID: 2069847 [TBL] [Abstract][Full Text] [Related]
74. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance. Rozental JM; Levine RL; Nickles RJ J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974 [TBL] [Abstract][Full Text] [Related]
75. 31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin: comparison in three sublines with increasing resistance. Tausch-Treml R; Köpf-Maier P; Baumgart F; Gewiese B; Ziessow D; Scherer H; Wolf KJ Br J Cancer; 1991 Sep; 64(3):485-93. PubMed ID: 1911189 [TBL] [Abstract][Full Text] [Related]
76. NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line. de Jong S; Mulder NH; de Vries EG; Robillard GT Br J Cancer; 1991 Feb; 63(2):205-12. PubMed ID: 1847646 [TBL] [Abstract][Full Text] [Related]
77. Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. Steen RG Cancer Res; 1989 Aug; 49(15):4075-85. PubMed ID: 2663140 [TBL] [Abstract][Full Text] [Related]
78. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253 [TBL] [Abstract][Full Text] [Related]
79. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy. Li SJ; Wehrle JP; Rajan SS; Steen RG; Glickson JD; Hilton J Cancer Res; 1988 Sep; 48(17):4736-42. PubMed ID: 3409214 [TBL] [Abstract][Full Text] [Related]
80. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. Daly PF; Cohen JS Cancer Res; 1989 Feb; 49(4):770-9. PubMed ID: 2643462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]